Pheromone Sciences Corp. (“Pheromone”) (TSX VENTURE: PHS) is pleased to announce that it has established a Business Advisory Board to strategically guide the directors and management in commercializing the Company’s diabetes product. Pheromone has appointed three former Company directors to the board: William Milligan, Andrew Saxton and Christopher Neuman.
